Nutrição e Esteatose – Artigo 13

Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol AbstractBackground: Recently factors in the relationship between gut microbiota, obesity, diabetes and the metabolic syndrome have been suggested in the development and progression of nonalcoholic steatohepatitis (NASH). In this sense, this work aims to evaluate the effects of probiotic supplementation on intestinal microbiota modulation, ...

Nutrição e Esteatose – Artigo 12

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy Abstract: The gut microbiota plays critical roles in development of obese-related metabolic diseases such as nonalcoholic fatty liver disease (NAFLD), type 2 diabetes(T2D), and insulin resistance(IR), highlighting the potential of gut microbiota-targeted therapies in these diseases. There are various ways that gut microbiota can be manipulated, including ...

Nutrição e Esteatose – Artigo 11

Gut-Liver Axis, Nutrition, and Non Alcoholic Fatty Liver Disease AbstractNonalcoholic fatty liver disease (NAFLD) represents a spectrum of diseases involving hepatic fat accumulation, inflammation with the potential progression to fibrosis and cirrhosis over time. NAFLD is often associated with obesity, insulin resistance, and diabetes. The interactions between the liver and the gut, the so-called ”gut-liver axis”, play a critical role ...

Nutrição e Esteatose – Artigo 10

Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field AbstractPurpose of review—Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and it has overlapping pathogenesis with diabetes and cardiovascular disease. Reviewed here are recent advances in understanding the contribution of diet and selectednutrients to NAFLD. Recent findings—To understand the effect of ...

Nutrição e Esteatose – Artigo 9

Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease1–3 ABSTRACTNonalcoholic fatty liver disease (NAFLD) can range in spectrum from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH), which ischaracterized by lipotoxicity, hepatocellular ballooning, and inflammation and can progress to cirrhosis. Weight loss is the cornerstone treatment for NAFLD and NASH. Various randomized controlled trials have ...

Nutrição e Esteatose – Artigo 8

Nonalcoholic fatty liver disease (NAFLD) prevention: role of Mediterranean diet and physical activity Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in Western countries leading to high morbidity and mortality and is strongly related to obesity (1). Indeed, metabolic syndrome and insulin resistance play a role in the pathogenesis of NAFLD, which involves intrahepatic triglyceride accumula...

Nutrição e Esteatose – Artigo 7

Dietary approach in the treatment of nonalcoholic fatty liver disease AbstractNonalcoholic fatty liver disease (NAFLD) has been identified as one of the most prevalent chronic liver disease in adults and children populations. NAFLD is usually associated with the metabolic syndrome (MS), which is chiefly related to insulin resistance and its consequences. Insulin resistance has a crucial role in the pathogenesis of hepatic steatosis and ...

Nutrição e Esteatose – Artigo 6

Mediterranean diet and nonalcoholic fatty liver disease AbstractNonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease, and is characterized by a wide spectrum of fat-liver disorders that can result in severe liver disease and cirrhosis. Inflammation and oxidative stress are the major risk factors involved in the pathogenesis of NAFLD. Currently, there is no consensus concerning the pharmacological ...